179 related articles for article (PubMed ID: 17172580)
1. New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia.
Dressler D; Adib Saberi F
J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):108-9. PubMed ID: 17172580
[No Abstract] [Full Text] [Related]
2. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.
Dressler D
J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):604; author reply 604. PubMed ID: 12397170
[No Abstract] [Full Text] [Related]
3. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
5. Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy.
Lee SK
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S105-10. PubMed ID: 17278332
[TBL] [Abstract][Full Text] [Related]
6. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc.
Dressler D; Hallett M
Eur J Neurol; 2006 Feb; 13 Suppl 1():11-5. PubMed ID: 16417592
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.
Dressler D; Bigalke H
J Neurol; 2005 Aug; 252(8):904-7. PubMed ID: 15761672
[TBL] [Abstract][Full Text] [Related]
8. Cervical dystonia: clinical and therapeutic features in 85 patients.
Camargo CH; Teive HA; Becker N; Baran MH; Scola RH; Werneck LC
Arq Neuropsiquiatr; 2008 Mar; 66(1):15-21. PubMed ID: 18392407
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of the dose consistency of botulinum toxin type A (BOTOX) for cervical dystonia.
Brashear A; Hogan P; Wooten-Watts M; Marchetti A; Magar R; Martin J
Adv Ther; 2005; 22(1):49-55. PubMed ID: 15943222
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
11. Xeomin(®) use in patients with systemic immune reactions to other botulinum toxins type A.
Ricciardi L; Bove F; Fasano A
Eur J Neurol; 2013 Mar; 20(3):e45-e46. PubMed ID: 23406455
[No Abstract] [Full Text] [Related]
12. Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA.
Coleman C; Hubble J; Schwab J; Beffy JL; Picaut P; Morte C
Int J Neurosci; 2012 Jul; 122(7):358-62. PubMed ID: 22356470
[TBL] [Abstract][Full Text] [Related]
13. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
Ranoux D; Gury C; Fondarai J; Mas JL; Zuber M
J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):459-62. PubMed ID: 11909903
[TBL] [Abstract][Full Text] [Related]
14. The finding and evaluation of EMG-guided BOTOX injection in cervical dystonia.
Lee LH; Chang WN; Chang CS
Acta Neurol Taiwan; 2004 Jun; 13(2):71-6. PubMed ID: 15478678
[TBL] [Abstract][Full Text] [Related]
15. New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.
Hussar DA; Kaczinski J
J Am Pharm Assoc (2003); 2010; 50(3):436-9. PubMed ID: 20452924
[No Abstract] [Full Text] [Related]
16. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
Mueller J
Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
[No Abstract] [Full Text] [Related]
17. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
Wynn RL
Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
[No Abstract] [Full Text] [Related]
18. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry.
Trosch RM; Espay AJ; Truong D; Gil R; Singer C; LeWitt PA; Lew MF; Tagliati M; Adler CH; Chen JJ; Marchese D; Comella CL
J Neurol Sci; 2017 May; 376():84-90. PubMed ID: 28431634
[TBL] [Abstract][Full Text] [Related]
19. The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.
Brashear A
Expert Opin Drug Saf; 2005 Mar; 4(2):241-9. PubMed ID: 15794717
[TBL] [Abstract][Full Text] [Related]
20. Can I treat this pregnant patient with botulinum toxin?
Pearce CS
Pract Neurol; 2014 Feb; 14(1):32-3. PubMed ID: 24390703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
